EANS-Adhoc: CHRIST WATER TECHNOLOGY AG / CHRIST Extraordinary General Meeting gives green light for new structure

ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.

07.08.2009

Today´s Extraordinary General Meeting of Christ Water Technology AG unanimously agreed to sell the Pharma & Life Sciences business and approved the sale and transfer contract with BWT AG.

Votes present: 5,636,838
Votes YES: 5,633,406
Votes NO: 0
Abstentions: 3,432 votes
The resolution was passed with: 100.00%

Upon successful completion, CHRIST will focus in water technology on the globally active businesses Desalination and Municipal Water, Ultrapure Water, green technologies and industrial wastewater treatment and wastewater recycling.

end of announcement euro adhoc

emitter: CHRIST WATER TECHNOLOGY AG Walter-Simmer-Straße 4 A-5310 Mondsee phone: +43/6232/5011-1001 FAX: +43/6232/5011-1109 mail: office@christ-water.com WWW: www.christ-water.com sector: Biotechnology ISIN: AT0000499157 indexes: WBI, ATX Prime stockmarkets: official market: Wien language: English

Rückfragen & Kontakt:

Christ Water Technology AG
Mag. Ralf Burchert
ralf.burchert@christwater.com
Tel.: 06232/5011-1113

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS | OTB0022